Valley National Advisers’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Valley National Advisers’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$156K	Hold	1,321	–	–	0.02%	287
2026 Q1	$137K	Sell	1,321 -858	-39%	-$90.6K	0.02%	279
2025 Q4	$227K	Hold	2,179	–	–	0.03%	230
2025 Q3	$201K	Hold	2,179	–	–	0.03%	234
2025 Q2	$174K	Sell	2,179 -183	-8%	-$14.6K	0.03%	246
2025 Q1	$204K	Buy	+2,362	New	+$201K	0.04%	231
2020 Q3	–	Sell	-160	Closed	-$10K	–	824
2020 Q2	$10K	Hold	160	–	–	﹤0.01%	477
2020 Q1	$9K	Sell	160 -108	-40%	-$6.58K	﹤0.01%	478
2019 Q4	$17K	Hold	268	–	–	﹤0.01%	455
2019 Q3	$15K	Hold	268	–	–	﹤0.01%	467
2019 Q2	$16K	Hold	268	–	–	﹤0.01%	426
2019 Q1	$17K	Hold	268	–	–	﹤0.01%	411
2018 Q4	$17K	Hold	268	–	–	0.01%	393
2018 Q3	$20K	Hold	268	–	–	0.01%	359
2018 Q2	$18K	Hold	268	–	–	0.01%	362
2018 Q1	$17K	Hold	268	–	–	0.01%	351
2017 Q4	$17K	Hold	268	–	–	0.01%	353
2017 Q3	$18K	Hold	268	–	–	0.01%	347
2017 Q2	$17K	Hold	268	–	–	0.01%	343
2017 Q1	$16K	Hold	268	–	–	0.01%	346
2016 Q4	$15K	Hold	268	–	–	0.01%	351
2016 Q3	$17K	Hold	268	–	–	0.01%	319
2016 Q2	$17K	Hold	268	–	–	0.01%	324
2016 Q1	$16K	Hold	268	–	–	0.01%	330
2015 Q4	$19K	Buy	+268	New	+$19K	0.01%	305

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Valley National Advisers's PJP Position: Q2 2026 in Review

Valley National Advisers held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 1,321 shares worth $156K. The position accounts for 0.02% of the portfolio, ranked #287.

Valley National Advisers first reported a position in PJP in Q4 2015 and has held it in 25 quarters since. The position peaked at $227K in Q4 2025. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Valley National Advisers held 1,321 shares of Invesco Pharmaceuticals ETF worth $156K as of Q2 2026.
Valley National Advisers left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
Invesco Pharmaceuticals ETF made up 0.02% of Valley National Advisers's portfolio in Q2 2026, its #287 holding.
Valley National Advisers first reported a position in Invesco Pharmaceuticals ETF in Q4 2015 and has held it in 25 quarters since.
Valley National Advisers's Invesco Pharmaceuticals ETF position peaked at $227K in Q4 2025.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.